{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-26-004245","form_type":"8-K","ticker":"NRXP","cik":"0001719406","company_name":"NRX Pharmaceuticals, Inc.","filed_at":"2026-02-17T23:59:59+00:00","discovered_at":"2026-05-14T18:02:35.995561+00:00","generated_at":"2026-05-16T02:27:54.948688+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.45,"calibrated_materiality_score":0.45,"confidence":"high","headline":"NRx Pharmaceuticals files $20M ATM offering for common stock","bullets":["Filed prospectus supplement for up to $20M of common stock via ATM with H.C. Wainwright & Co.","Shares to be issued under S-3 registration statement declared effective December 22, 2025.","Legal opinion from Cozen O'Connor on share validity filed as Exhibit 5.1.","No specific sales, pricing, or use of proceeds disclosed in the filing."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-26-004245","json":"https://secwatch.observer/filing/0001437749-26-004245.json","markdown":"https://secwatch.observer/filing/0001437749-26-004245.md","text":"https://secwatch.observer/filing/0001437749-26-004245.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1719406/000143774926004245/0001437749-26-004245-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1719406/000143774926004245/nrxp20260216_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T02:27:54.948688+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}